Unusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin
Articles > Article · 2014
Authors: HALİL BOZKAYA, Celal ÇİNAR, ÖMER VEDAT ÜNALP, Mustafa PARILDAR, İsmail ORAN
WIENER KLINISCHE WOCHENSCHRIFT, Journal Indexed in SCI Expanded, International, 2014, vol 127, pp 488-490
DOI: 10.1007/s00508-014-0675-5
Summary
Kasabach-Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin.